📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Drug metabolism in the lungs: opportunities for optimising inhaled medicines. (2021)

First Author: Enlo-Scott Z

Attributed to: Component-Specific Air pollutant Drivers of Disease Risk in Early to Midlife: a pathway approach. (DREaM) funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/17425255.2021.1908262

PubMed Identifier: 33759677

Publication URI: http://europepmc.org/abstract/MED/33759677

Type: Journal Article/Review

Volume: 17

Parent Publication: Expert opinion on drug metabolism & toxicology

Issue: 5

ISSN: 1742-5255